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===================

The most commonly studied member of the genus *Serratia* is the pathogenic *Serratia marcescens*, a producer of a red prodigiosin pigment ([@B1]). *Serratia liquefaciens* and *S. marcescens* are often associated with nosocomial infections that involve the colonization of medical devices ([@B2], [@B3]). Strains belonging to this genus are known to harbor diverse antibiotic resistance determinants ([@B3][@B4][@B8]).

Other species belonging to this genus have been described as being indirectly beneficial to humans because they produce highly potent antifungal and antimicrobial molecules. Such is the case of *Serratia plymuthica* strain HRO-C48, which was isolated from the rhizosphere of oilseed rape and produces the antifungal pyrrolnitrin ([@B9], [@B10]), and of *S. plymuthica* RVH1, which was isolated from a raw vegetable-processing line and produces the antimicrobial zeamine ([@B11], [@B12]).

*Serratia* sp. strain V4 (ZK4911) was isolated from a biofilm that formed on the pasteurizer plate in a sanitized milk-processing line ([@B13]). This strain was particularly interesting, as it was found to produce the siderophore serratiochelin ([@B14]) as well as a number of uncharacterized antimicrobial compounds and the recently characterized zeamine ([@B11], [@B13]).

Genomic DNA from *Serratia* sp. V4 was obtained from an overnight culture in LB medium (Merck) using the total DNA extraction DNeasy blood and tissue kit (Qiagen). The genome sequence was obtained by *de novo* sequencing using 454 technology (Genotech, South Korea), which resulted in 65 contigs with an average length of 85 kb (contig size range, 10 to 457 kb; *N*~50~, 220 kb). The relative order and orientation of the contigs were determined by comparison with whole-genome sequences available from other members of the genus, those of *Serratia* sp. strain AS12 (GenBank accession no. CP002774.1), *S. plymuthica* 4x13 (previously *Serratia odorifera* 4Rx13; GenBank accession no. CP006250), and *Serratia proteamaculans* 568 (GenBank accession no. CP000826.1), using the whole-genome alignment tool Mauve version 2.3.1 ([@B15]). Based on this scaffolding, we were able to close 52 gaps by PCR and primer walking, thus yielding 13 supercontigs.

The genome of *Serratia* sp. V4 is approximately 5.5 Mb long, with a G+C content of 56%, falling within the normal *Serratia* genus values (54 to 60%) ([@B16]). The genome of *Serratia* sp. strain V4 displays a high degree of similarity (98% nucleotide identity) with the genome of *S. plymuthica* 4Rx13, though *S. plymuthica* 4Rx13 lacks key gene clusters involved in the biosynthesis of nonribosomal peptides and polyketides. For example, it lacks genes involved in the synthesis of zeamine ([@B17]), as confirmed by BLAST analyses.

Digital DNA-DNA hybridization (genome-to-genome distance calculator; German Collection of Microorganisms and Cell Cultures \[DSMZ\]) confirmed that *S. plymuthica* 4Rx13 is indeed the closest relative of *Serratia* sp. V4 ([@B18]). Formula 2 (sum of all identities found in high-scoring segment pairs \[HSPs\] divided by the overall HSP length), which is preferred for incomplete genomes such as this one, gave a percentage of 96.41 for the likelihood of these being the same species. Thus, we are designating this strain *S. plymuthica* strain V4.

Nucleotide sequence accession number. {#h1}
-------------------------------------

The genomic sequence of *S. plymuthica* V4 has been deposited in GenBank under the accession no. [CP007439](http://www.ncbi.nlm.nih.gov/nuccore?term=CP007439).
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